Welcome to our dedicated page for Amerisafe SEC filings (Ticker: AMSF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AMERISAFE, Inc. (NASDAQ: AMSF) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. AMERISAFE is a specialty provider of workers’ compensation insurance for small to mid-sized employers in high-hazard industries, and its filings offer detailed insight into underwriting results, investment performance, and capital management decisions.
Current reports on Form 8-K featured here include announcements of quarterly financial results, special and regular cash dividends, share repurchase program authorizations, and executive leadership changes. For example, 8-K filings describe the company’s second- and third-quarter 2025 results, the reauthorization of a $25.0 million share repurchase program, and the planned resignation of its Executive Vice President and Chief Financial Officer.
Investors can also use this page to locate AMERISAFE’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which expand on the summary data in press releases. These filings typically include segment-level information on gross premiums written, net premiums earned, loss and loss adjustment expenses, underwriting and operating costs, policyholder dividends, and net investment income, along with discussions of risk factors and capital resources.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from long filings, helping readers quickly identify trends in combined ratios, reserve development, and investment income. The platform also surfaces insider transaction reports on Form 4, where applicable, so users can track equity transactions by AMERISAFE officers and directors alongside the company’s broader financial disclosures.
By combining real-time EDGAR updates with AI explanations, this page helps users navigate AMERISAFE’s SEC filings more efficiently and understand how its workers’ compensation focus, underwriting results, and capital management activities are reflected in official regulatory documents.
AMERISAFE Inc ownership filing: The Vanguard Group amended its Schedule 13G to report 0 shares beneficially owned of Common Stock, representing 0% of the class. The amendment states Vanguard reorganized on January 12, 2026 and now reports certain subsidiaries separately in reliance on SEC Release No. 34-39538.
AMERISAFE Inc. executive vice president and Chief Risk Officer Vincent J. Gagliano received a grant of 6,392 shares of common stock on March 12, 2026 at no cost as equity compensation. To cover tax obligations, 2,708 shares were withheld at $32.92 per share, leaving him with 31,523 shares held directly after these transactions.
AMERISAFE INC executive Kathryn Shirley Housh reported routine equity compensation activity. On March 12, 2026, she received a grant of 5,905 shares of common stock at a price of 0.0000 per share as part of a grant or award.
On the same date, 2,501 shares were disposed of at 32.9200 per share to satisfy tax withholding obligations, a non-market transaction coded as a tax-liability payment. After these transactions, she directly holds 24,751 shares of AMERISAFE common stock.
AMERISAFE EVP–CSO Raymond F. Wise Jr. received a grant of 5,694 shares of common stock on March 12, 2026 at no cost, increasing his holdings to 9,029 shares before related taxes. To cover tax obligations, 2,468 shares were withheld at a price of $32.92 per share, leaving him with 6,561 shares held directly.
AMERISAFE INC President & CEO Janelle Frost reported routine equity compensation activity. She received a grant of 24,814 shares of common stock at no cost, increasing her direct holdings before tax actions. On the same date, 10,509 shares were disposed of to cover tax obligations at a price of $32.92 per share, which is not an open-market sale. After these transactions, she directly owns 129,531 shares of AMERISAFE common stock.
AMERISAFE, Inc. executive Vincent J. Gagliano, EVP and Chief Risk Officer, received a grant of 2,386 restricted stock units. Each unit represents a contingent right to receive one share of Amerisafe common stock and the award fully vests on March 1, 2029.
Following this compensation grant, Gagliano holds 5,234 restricted stock units in total. The Form 4 classifies the transaction as a grant or award acquisition rather than an open-market purchase or sale of shares.
Wise Raymond F. Jr. reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE Inc. Executive Vice President and Chief Sales Officer Raymond F. Wise Jr. received a grant of 2,225 restricted stock units as equity compensation. Each unit represents a contingent right to receive one share of AMERISAFE common stock. Following this award, he now directly holds 14,135 restricted stock units. The newly granted units are scheduled to fully vest on March 1, 2029, meaning the underlying shares will only be delivered if the vesting conditions are satisfied over time.
Frost G. Janelle reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE, Inc. President and CEO Janelle Frost received a grant of 8,326 restricted stock units, each representing a contingent right to one share of common stock. These units fully vest on March 1, 2029. Following this award, she holds 18,274 restricted stock units directly.
Shirley Kathryn Housh reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC executive Shirley Kathryn Housh, EVP and Chief Accounting Officer, received a grant of 2,118 restricted stock units. Each unit represents a contingent right to receive one share of Amerisafe common stock. Following this award, she holds 4,618 restricted stock units directly, which fully vest on March 1, 2029.
AMERISAFE INC executive Raymond F. Wise Jr., EVP – CSO, reported equity compensation activity involving restricted stock units and common shares. On March 1, 2026, 1,044 restricted stock units fully vested and were converted into 1,044 shares of common stock at a stated price of $0.00 per share. In a related move, 503 common shares were disposed of at $32.53 per share to satisfy tax-withholding obligations, leaving Wise with 3,335 directly owned common shares and 11,910 restricted stock units following the transactions.